Neurite regeneration in adult rat retinas exposed to advanced glycation end-products and regenerative effects of neurotrophin-4

Brain Research

Volumn 1534, Issue , 2013, Pages 33-45

  Bikbova, Guzel ^a   Oshitari, Toshiyuki ^a   Yamamoto, Shuichi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AGE; AIF; Apoptosis; Caspase 9; NT 4; Regeneration

Indexed keywords

ADVANCED GLYCATION END PRODUCT; APOPTOSIS INDUCING FACTOR; BOVINE SERUM ALBUMIN; CASPASE 9; COLLAGEN GEL; GLUCOSE; GLYCERALDEHYDE; NEUROTROPHIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; CULTURE MEDIUM; EXPLANT; IMMUNOHISTOCHEMISTRY; MALE; NEURITE; NEURITIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REGENERATIVE ABILITY; RETINA; RETINA GANGLION CELL; SPRAGUE DAWLEY RAT;

BOVINAE; RATTUS;

4,6-DIAMIDINO-2-PHENYL INDOLE; ADVANCED GLYCATION END-PRODUCTS; AGE; AGES; AIF; ANALYSIS OF VARIANCE; ANOVA; APOPTOSIS; APOPTOSIS-INDUCING FACTOR; BOVINE SERUM ALBUMIN; BSA; CASPASE-9; DAPI; GANGLION CELL LAYER; GCL; INL; INNER NUCLEAR LAYER; NEUROTROPHIN-4; NT-4; ONL; OUTER NUCLEAR LAYER; RAGE; RECEPTOR FOR AGE; REGENERATION; RETINAL GANGLION CELLS; RGCS; SD; SPRAGUE-DAWLEY; TDT-DUTP TERMINAL NICK-END LABELING; TUNEL; VASCULAR ENDOTHELIAL NEUROTROPHIC FACTOR; VEGF;

ANIMALS; APOPTOSIS; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; NERVE GROWTH FACTORS; NERVE REGENERATION; NEURITES; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS;

EID: 84884670547     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.08.027     Document Type: Article

References (64)

1. S. Amano, Y. Kaji, T. Oshika, T. Oka, R. Machinami, R. Nagai, and S. Horiuchi Advanced glycation end products in human optic nerve head Br. J. Ophthalmol. 85 2001 52 55
2. N. Araki, N. Ueno, B. Chakrabarti, Y. Morino, and S. Horiuchi Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging J. Biol. Chem. 267 1992 10211 10214
3. A.J. Bailey, R.G. Paul, and L. Knott Mechanisms of maturation and ageing of collagen Mech. Ageing Dev. 106 1998 1 56
4. W.K. Bolton, D.C. Cattran, M.E. Williams, S.G. Adler, G.B. Appel, K. Cartwright, P.G. Foiles, B.I. Freedman, P. Raskin, R.E. Ratner, B.S. Spinowitz, F.C. Whittier, J.P. Wuerth, I ACTION Investigator Group Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy Am. J. Nephrol. 24 2004 32 40
5. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications N. Engl. J. Med. 318 1988 1315 1320
6. D. Dyer, J. Blackledge, S. Thorpe, and J. Baynes Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo J. Biol. Chem. 266 1991 11654 11660
7. J.E. Frampton Ranibizumab: in diabetic macular oedema Drugs 72 2012 509 523
8. M. Gul, S. Emre, M. Esrefoglu, and N. Vard Protective effects of melatonin and aminoguanidine on the cornea in streptozotocininduced diabetic rats Cornea 27 2008 795 801
9. S. Ghazi-Nouri, J.S. Ellis, S. Moss, G.A. Limb, and D.G. Charteris Expression and localisation of BDNF, NT4 and TrkB in proliferative vitreoretinopathy Exp. Eye Res. 86 2008 819 827
10. D.R. Green, and G. Kroemer The pathophysiology of mitochondrial cell death Science 305 2004 626 629
11. H.P. Hammes, A. Alt, T. Niwa, J.T. Clausen, R.G. Bretzel, M. Brownlee, and E.D. Schleicher Differential accumulation of advanced glycation end products in the course of diabetic retinopathy Diabetologia 42 1999 728 736
12. H. Horie, Y. Bando, H. Chi, and T. Takenaka NGF enhances neurite regeneration from nerve-transected terminals of young adult and aged mouse dorsal root ganglia in vitro Neurosci. Lett. 121 1991 125 128
13. H. Horie, and M. Takano Tissue culture method for neuronal regeneration of postnatal and mature mammalian retina Tissue Culture Res. Commun. 13 1994 171 178
14. Y. Kaji, S. Amano, T. Usui, T. Oshika, K. Yamashiro, S. Ishida, K. Suzuki, S. Tanaka, A.P. Adamis, R. Nagai, and S. Horiuchi Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells Invest. Ophthalmol. Vis. Sci. 44 2003 521 528
15. T. Kalfa, M. Gerritsen, E. Carlson, A. Binstock, and E. Tsilibary Altered proliferation of retinal microvascular cells on glycated matrix Invest. Ophthalmol. Vis. Sci. 36 1995 2358 2367
16. S. Kase, S. Ishida, and N. Rao Immunolocalization of advanced glycation end products in human diabetic eyes: an immunohistochemical study J. Diabetes Mellitus 1 2011 57 62
17. M. Kasper, C. Roehlecke, M. Witt, H. Fehrenbach, A. Hofer, T. Miyata, C. Weigert, R.H. Funk, and E.D. Schleicher Induction of apoptosis by glyoxal in human embryonic lung epithelial cell line L132 Am. J. Respir. Cell Mol. Biol. 23 2000 485 491
18. E. Kawano, S. Takahashi, Y. Sakano, and D. Fujimoto Nonenzymatic glycation alters properties of collagen as a substratum for cells Matrix 10 1990 300 305
19. A. Lecleire-Collet, L.H. Tessier, P. Massin, V. Forster, G. Brasseur, J.A. Sahel, and S. Picaud Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants Br J. Ophthalmol. 89 2005 1631 1633
20. M. Lu, M. Kuroki, S. Amano, M. Tolentino, K. Keough, I. Kim, R. Bucala, and A.P. Adamis Advanced glycation end products increase retinal vascular endothelial growth factor expression J. Clin. Invest. 101 1998 1219 1224
21. L. Ma, and L.F. Nicholson Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus Brain Res. 1018 2004 10 17
22. M. Marion, and E. Carlson Immunoelectron microscopic analyses of Maillard reaction products in bovine anterior lens capsule and Descemet's membrane Biochim. Biophys. Acta 1191 1994 33 42
23. N. Modjtahedi, F. Giordanetto, F. Madeo, and G. Kroemer Apoptosis-inducing factor: vital and lethal Trends Cell Biol. 16 2006 264 272
24. T. Murata, T. Ishibashi, R. Nagai, S. Horiuchi, and S. Amano Advanced glycation end products in diabetic corneas Invest. Ophthalmol. Vis. Sci. 41 2000 362 368
25. Y. Ono, S. Aoki, K. Ohnishi, T. Yasuda, T. Kawano, and Y. Tsukada Diabetes Res. Clin. Pract. 41 1998 131 137
26. T. Oshitari, and E. Adachi-Usami The effect of caspase inhibitors and neurotrophic factors on damaged retinal ganglion cells Neuro Report 14 2003 289 292
27. T. Oshitari, and S. Roy Diabetes: a potential enhancer of retinal injury in rat retinas Neurosci. Lett. 390 2005 25 30
28. T. Oshitari, M. Dezawa, S. Okada, M. Takano, H. Negishi, H. Horie, H. Sawada, T. Tokuhisa, and E. Adachi-Usami The role of c-fos in cell death and regeneration of retinal ganglion cells Invest. Ophthalmol. Vis. Sci. 43 2002 2442 2449
29. T. Oshitari, N. Fujimoto, and E. Adachi-Usami Citicoline has a protective effect on damaged retinal ganglion cells in mouse culture retina Neuro Report 13 2002 2109 2111
30. T. Oshitari, S. Okada, T. Tokuhisa, and E. Adachi-Usami Adenovirus-mediated gene transfer of Bcl-xL impedes neurite regeneration in vitro Neuro Report 14 2003 1159 1162
31. T. Oshitari, S. Yamamoto, N. Hata, and S. Roy Mitochondria- and caspase dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy Br. J. Ophthalmol. 92 2008 552 556
32. T. Oshitari, N. Hata, and S. Yamamoto Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose Brain Res. 1346 2010 43 51
33. T. Oshitari, N. Yoshida-Hata, and S. Yamamoto Effect of neurotrophin-4 on endoplasmic reticulum stress-related neuronal apoptosis in diabetic and high glucose exposed rat retinas Neurosci. Lett. 501 2011 102 106
34. M. Parravano, F. Menchini, and G. Virgili Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema Cochrane Database Syst. Rev. 4 2009 CD007419
35. M. Peppa, J. Uribarri, and H. Vlassara Glucose, advanced glycation end products, and diabetes complications: what Is new and what works Clin. Diabetes 21 2003 186 187
36. H. Quigley, and S. Vitale Models of open-angle glaucoma prevalence and incidence in the United States Invest. Ophthalmol. Vis. Sci. 38 1997 83 91
37. L.F. Reichardt Neurotrophin-regulated signalling pathways Philos. Trans. R. Soc. London B Biol. Sci. 361 2006 1545 1564
38. N. Ruderman, J. Williamson, and M. Brownlee Glucose and diabetic vascular disease FASEB J. 6 1992 2905 2914
39. B. Sabirzhanov, B.A. Stoica, M. Hanscom, C.S. Piao, and A.I. Faden Over-expression of HSP70 attenuates caspase-dependent and caspase-independent pathways and inhibits neuronal apoptosis J. Neurochem. 123 2012 542 554
40. C. Sady, S. Khosrof, and R. Nagaraj Advanced Maillard reaction and crosslinking of corneal collagen in diabetes Biochem. Biophys. Res. Commun. 214 1995 793 797
41. D. Sell, and V. Monnier Structure elucidation of senescence cross-link from human extracellular matrix: implication of pentoses in the aging process J. Biol. Chem. 264 1989 21597 21602
42. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The biology of the receptor for advanced glycation end products and its ligands Biochim. Biophys. Acta 1498 2000 99 111
43. A. Stitt Advanced glycation: an important pathological event in diabetic and age related ocular disease Br. J. Ophthalmol. 85 2001 746 753
44. A. Stitt, T. Bhaduri, C.B. McMullen, T.A. Gardiner, and D.B. Archer Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats Mol. Cell Biol. Res. Commun. 3 2000 380 388
45. A. Stitt, T.A. Gardiner, N.L. Alderson, P. Canning, N. Frizzell, N. Duffy, C. Boyle, A.S. Januszewski, M. Chachich, J.W. Baynes, and S.R. Thorpe The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes Diabetes 51 2002 2826 2832
46. A. Stitt AGEs and diabetic retinopathy Invest. Ophthalmol. Vis. Sci. 10 2010 4867 4874
47. S.A. Susin, N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, and G. Kroemer Bcl-2 inhibits the mitochondrial release of an apoptogenic protease J. Exp. Med. 184 1996 1331 1341
48. S.A. Susin, H.K. Lorenzo, N. Zamzami, I. Marzo, B.E. Snow, G.M. Brothers, J. Mangion, E. Jacotot, P. Costantini, M. Loeffler, N. Larochette, D.R. Goodlett, R. Aebersold, D.P. Siderovski, J.M. Penninger, and G. Kroemer Molecular characterization of mitochondrial apoptosis-inducing factor Nature 397 1999 441 446
49. M. Takano, K. Sango, H. Horie, M. Sato, Y. Iijima, S. Ohno, S. Inoue, and Y. Ishikawa Diabetes alters neurite regeneration from mouse retinal explants in culture Neurosci. Lett. 275 1999 175 178
50. G. Tezel, C. Luo, and X. Yang Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head Invest. Ophthalmol. Vis. Sci. 3 2007 1201 1211
51. P.J. Thornalley Cell activation by glycated proteins: AGE receptors, receptor recognition factors and functional classification of AGEs Cell Mol. Biol. 44 1998 1013 1023
52. C. Treins, S. Giorgetti-Peraldi, J. Murdaca, and E. Van Obberghen Regulation of vascular endothelial growth factor expression by advanced glycation end products J. Biol. Chem. 276 2001 43836 43841
53. S. Vasan, P. Foiles, and H. Founds Therapeutic potential of breakers of advanced glycation end product-protein crosslinks Arch. Biochem. Biophys. 419 2003 89 96
54. P.A. Voziyan, T.O. Metz, J.W. Baynes, and B.G. Hudson A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation J. Biol. Chem. 277 2002 3397 3403
55. J. Wautier, M. Wautier, A. Schmidt, and G. Anderson Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surfaceassociated AGEs and diabetic complications Proc. Natl. Acad. Sci. 91 1994 7742 7746
56. F.R. Wiedemann, D. Siemen, C. Mawrin, T.F. Horn, and K. Dietzmann The neurotrophin receptor TrkB is colocalized to mitochondrial membranes Int. J. Biochem. Cell Biol. 38 2006 610 620
57. C.K. Wong, Z. Chen, K.L. So, D. Li, and P. Li Polycomb group protein RING1B is a direct substrate of Caspases-3 and -9 Biochim. Biophys. Acta 1773 2007 844 852
58. S. Yamagishi, H. Fujimori, H. Yonekura, Y. Yamamoto, and Y. Yamamoto Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells Diabetologia 41 1998 1435 1441
59. S.D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, and A.M. Schmidt RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease Nature 382 1996 685 691
60. S.D. Yan, A.M. Schmidt, G.M. Anderson, J. Zhang, J. Brett, Y.S. Zou, D. Pinsky, and D. Stern Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins J. Biol. Chem. 269 1994 9889 9897
61. W. Yin, G. Cao, M.J. Johnnides, A.P. Signore, Y. Luo, R.W. Hickey, and J. Chen TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF Neurobiol. Dis. 21 2006 358 371
62. K. Yoshihara, T. Okumura, T. Yoshida, and M. Beppu Inhibitory Effect of peptide-free forms of advanced glycation end products on the proliferation and extracellular matrix protein production of cultured cells J. Health Sci. 47 2001 296 301
63. P. Younessi, and A. Yoonessi Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress Iran J. Med. Sci. 36 2011 154 166
64. I. Zechmeister-Koss, and M. Huic Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review Br. J. Ophthalmol. 96 2012 167 178